Viewing Study NCT04872634


Ignite Creation Date: 2025-12-25 @ 2:37 AM
Ignite Modification Date: 2025-12-30 @ 12:45 PM
Study NCT ID: NCT04872634
Status: UNKNOWN
Last Update Posted: 2021-07-21
First Post: 2021-04-21
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Safety and Anti-tumor Activity of SNK01 (NK Cells) Administered in Combination With Chemotherapy or Chemotherapy / Cetuximab in Local Advanced or Metastatic Non-small Cell Lung Cancer Patients Who Failed Tyrosine Kinase Inhibitor Treatment
Sponsor: NKMAX Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module